4-8-75
34.4
[]. Agnieszka Rajtar-Ciosek, et al. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration. Neuro Endocrinol Lett. ;3(3):34-4.
[]. Daisuke Akashi, et al. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report. Jpn J Clin Oncol. 3 Nov;43():45-9.
[3]. Ireneusz Po?a?, et al. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol Endocrinol. 3 Feb;9():65-8.
[4]. John C Stevenson, et al. Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas. 3 Sep;76():-.
[5]. Julia Maria Naumann, et al. Biotechnological production of -alpha-dihydrodydrogesterone at pilot scale. Appl Biochem Biotechnol. Sep;65():9-3.
H3-H35-H39-H335
P6-P64-P7-P7-P8-P3+P35-P34+P34-P33-P36+P364-P45-P5
GHS7
6498 货期咨询
83966 货期咨询
￥ ľɁɁǼɁɁ -mg
639 货期咨询
6389 货期咨询
649 货期咨询
6398 货期咨询
沪ICP备79645号
